Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
暂无分享,去创建一个
O. Abdel-Wahab | R. Dickins | B. Neel | M. Figueroa | A. Tsirigos | I. Dolgalev | Robert S. Banh | Delphine Ndiaye-Lobry | L. Cimmino | I. Aifantis | M. Guillamot | Christopher Y. Park | A. Yoshimi | M. Witkowski | M. T. Martin | Mingjiang Xu | Matthew T. Witkowski | V. Ng | Sofia Bakogianni | Jingjing Wang | Marisa Mitchell-Flack | G. Martin | B. Xia | Yubao Wang | I. Grillo | Miguel Torres Martín | Miguel Torres Martín | Miguel Torres Martín | Maria Guillamot | Igor Dolgalev | Marisa Mitchell-Flack
[1] Tomas Radivoyevitch,et al. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells , 2017, Nature Communications.
[2] B. Ebert,et al. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.
[3] M. Levine,et al. Vitamin C: the known and the unknown and Goldilocks. , 2016, Oral diseases.
[4] Peter A. Jones,et al. Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine , 2016, Proceedings of the National Academy of Sciences.
[5] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[6] K. Helin,et al. Role of TET enzymes in DNA methylation, development, and cancer , 2016, Genes & development.
[7] L. Cimmino,et al. The Impact of DNA Methylation in Hematopoietic Malignancies. , 2016, Trends in cancer.
[8] Eugenia G. Giannopoulou,et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH , 2015, Science.
[9] A. Rao,et al. Acute loss of TET function results in aggressive myeloid cancer in mice , 2015, Nature Communications.
[10] R. Jaenisch,et al. Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation , 2015, Molecular and Cellular Biology.
[11] Juan I. Young,et al. Regulation of the Epigenome by Vitamin C. , 2015, Annual review of nutrition.
[12] B. Porse,et al. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis , 2015, Genes & development.
[13] C. Mason,et al. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. , 2015, Cancer cell.
[14] D. Neuberg,et al. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. , 2014, Blood.
[15] Chun-Xiao Song,et al. Mechanism and function of oxidative reversal of DNA and RNA methylation. , 2014, Annual review of biochemistry.
[16] S. Lowe,et al. Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice , 2014, PloS one.
[17] A. Zeidan,et al. Beyond hypomethylating agents failure in patients with myelodysplastic syndromes , 2014, Current opinion in hematology.
[18] G. Pan,et al. Vitamin C modulates TET1 function during somatic cell reprogramming , 2013, Nature Genetics.
[19] Shankar Balasubramanian,et al. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine , 2013, Nature Protocols.
[20] Zechen Chong,et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. , 2013, Journal of the American Chemical Society.
[21] Mohammad M. Karimi,et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells , 2013, Nature.
[22] William A. Pastor,et al. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription , 2013, Nature Reviews Molecular Cell Biology.
[23] K. Ando,et al. High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1α Transcription , 2013, PloS one.
[24] Jean Cadet,et al. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. , 2013, Cold Spring Harbor perspectives in biology.
[25] J. Cullen,et al. Ascorbic acid: chemistry, biology and the treatment of cancer. , 2012, Biochimica et biophysica acta.
[26] E. Ballestar,et al. Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells. , 2012, Molecular cell.
[27] M. De Felici,et al. Poly(ADP-ribosyl)ation Acts in the DNA Demethylation of Mouse Primordial Germ Cells Also with DNA Damage-Independent Roles , 2012, PloS one.
[28] Francine E. Garrett-Bakelman,et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles , 2012, Genome Biology.
[29] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[30] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[31] P. Opolon,et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.
[32] Johannes Zuber,et al. A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference , 2011, Cell.
[33] Zachary D. Smith,et al. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling , 2011, Nature Protocols.
[34] P. Laird,et al. Vitamin C Promotes Widespread Yet Specific DNA Demethylation of the Epigenome in Human Embryonic Stem Cells , 2010, Stem cells.
[35] Fabien Campagne,et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. , 2010, Cancer cell.
[36] H. Redl,et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.
[37] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[38] D. Birnbaum,et al. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia , 2009, Haematologica.
[39] Andreas Trumpp,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[40] D. Gilliland,et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.
[41] P. Lio’,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[42] D. Largaespada,et al. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells. , 2007, Experimental hematology.
[43] Christof Niehrs,et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.
[44] Rudolf Jaenisch,et al. Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues , 2005, Cell.
[45] L. Pauling,et al. Ascorbic acid and cancer: a review. , 1979, Cancer research.
[46] Jinming Gao,et al. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. , 2014, Critical reviews in eukaryotic gene expression.